questionText: To ask the Secretary of State for Health and Social Care, what assessment they have made of variations in access to Tirzepatide (Mounjaro) across Integrated Care Boards; and what steps they are taking to ensure consistency in prescribing for eligible patients.
answerText: Tirzepatide, brand name Mounjaro, is recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of both type 2 diabetes and obesity.Integrated care boards (ICBs) are legally required to fund NICE-recommended medicines, i...
heading: Tirzepatide